In Vitro p24 Antigen-Stimulated Lymphocyte Proliferation and β-Chemokine Production in Human Immunodeficiency Virus Type 1 (HIV-1)-Seropositive Subjects after Immunization with an Inactivated gp120-Depleted HIV-1 Immunogen (Remune)
- 1 May 1998
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 5 (3) , 308-312
- https://doi.org/10.1128/cdli.5.3.308-312.1998
Abstract
We examined the effect of immune stimulation by a human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) compared to a non-HIV vaccine (influenza) on HIV-1-specific immune responses in HIV-1-seropositive subjects. HIV-1 p24 antigen-stimulated lymphocyte proliferation was not augmented after immunization with the influenza vaccine. In contrast, subjects increased their lymphocyte proliferative responses to p24 antigen after one immunization with HIV-1 immunogen (Remune) (gp120-depleted inactivated HIV-1 in incomplete Freund’s adjuvant). Furthermore, p24 antigen-stimulated β-chemokine production (RANTES, MIP-1α, MIP-1β) was also augmented after immunization with the HIV-1 immunogen but not influenza vaccine. Taken together, these results suggest that in this cohort, HIV-specific immune responses to p24 antigen can be augmented after immunization with an HIV-1 immunogen. The ability to upregulate immune responses to the more conserved core proteins may have important implications in the development of immunotherapeutic interventions for HIV-1 infection.Keywords
This publication has 23 references indexed in Scilit:
- Production of β‐Chemokines in Human Immunodeficiency Virus (HIV) Infection: Evidence that High Levels of Macrophage Inflammatory Protein‐1β Are Associated with a Decreased Risk of HIV Disease ProgressionThe Journal of Infectious Diseases, 1998
- Inhibition of HIV-1 Infection by the β-Chemokine MDCScience, 1997
- Effect of Therapeutic Immunization With Recombinant gp160 HIV-1 Vaccine on HIV-1 Proviral DNA and Plasma RNAJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Preliminary Evidence for Partial Restoration of Immune Function in HIV Type 1 Infection with Potent Antiretroviral Therapies: Clues from the Fourth Conference on Retroviruses and Opportunistic DiseasesAIDS Research and Human Retroviruses, 1997
- Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive SubjectsViral Immunology, 1997
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- In VitroLymphocyte Proliferative Response to HIV-1 p24 Is Associated with a Lack of CD4+Cell DeclineAIDS Research and Human Retroviruses, 1994
- Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.Journal of Clinical Investigation, 1989
- Lymphoproliferative Responses to Human Immunodeficiency Virus Antigen in Asymptomatic Intravenous Drug Abusers and in Patients with Lymphadenopathy or AIDSThe Journal of Infectious Diseases, 1987